Tuesday, January 6, 2026 1/6/2026

Comprehensive Assessment of Delirium Risk due to Medications

Award Number: R21AG084218
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/01/2023
PERIOD OF PERFORMANCE END DATE: 11/30/2026

Group Awards By:

View Award Description

Comprehensive Assessment of Delirium Risk due to Medications - ABSTRACT Delirium, or acute confusional state, affects 30-40% of hospitalized older adults, with the added cost of care es- timated to be up to $7 billion. Medications are one of the most common causes of delirium and potentially one of the most preventable and most treatable, with medications thought to be the sole precipitant for delirium in up to 39% of cases. Despite the critical role of medications as a source of delirium, surprisingly few studies have investigated this topic, often focused on only a few medications and with only modest quality. In this proposal, we will address these limitations by utilizing data collected through our Virtual Acute Care for Elders (ACE) quality improvement project, which instituted delirium screening once per shift by nursing staff for all individuals over age 65 admitted to University of Alabama at Birmingham (UAB) Hospital for the past decade. This unprecedented volume of data on more than 81,000 patients will allow us to achieve the necessary sample sizes for effective ap- plication of data mining algorithms. Data mining algorithms that discover patterns of associations in data, rather than testing predetermined hypotheses, are well suited to application in large-scale algorithms to identify med- ications associated with increased odds of delirium. Combining data mining with our Virtual ACE and hospital electronic health record (EHR) data, we will be able to evaluate more than 1,000 individual medications, as well as medication combinations and medication classes, for their association with delirium. Such a comprehensive, data-driven examination of delirium due to medications will be a significant contribution to our understanding of the risk factors and management of delirium in the older adult population.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	2	10/27/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $177,865 )
2025	2025	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	001	2	4/28/2025	NON-COMPETING CONTINUATION	$17,786
2025	2025	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	2	11/27/2024	NON-COMPETING CONTINUATION	$160,079
														Subtotal = $177,865

Issue Date FY: 2024 ( Subtotal = $214,990 )
2024	2024	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Aging Research	000	1	11/17/2023	NEW	$214,990
														Subtotal = $214,990

Grand Total All Awards = $392,855

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Comprehensive Assessment of Delirium Risk due to Medications

Award Number: R21AG084218

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/01/2023

PERIOD OF PERFORMANCE END DATE: 11/30/2026

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer